{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:51:03Z","timestamp":1775040663135,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Government Funded Clinical Medicine Excellent Talents Training Project of Hebei Province","award":["ZF2025052"],"award-info":[{"award-number":["ZF2025052"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-026-07921-5","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:26:33Z","timestamp":1772123193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The predictive value of niacin skin flushing response and inflammatory factors for the antidepressant efficacy"],"prefix":"10.1186","volume":"26","author":[{"given":"Meiyue","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuke","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuixia","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"1","key":"7921_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41572-023-00454-1","volume":"9","author":"W Marx","year":"2023","unstructured":"Marx W, Penninx B, Solmi M, Furukawa TA, Firth J, Carvalho AF, Berk M. Major depressive disorder. Nat Rev Dis Primers. 2023;9(1):44. https:\/\/doi.org\/10.1038\/s41572-023-00454-1. From NLM.","journal-title":"Nat Rev Dis Primers"},{"key":"7921_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.puhe.2024.06.011","volume":"237","author":"regional Global","year":"2024","unstructured":"Global regional. national burden of injuries, and burden attributable to injuries risk factors, 1990 to 2019: results from the Global Burden of Disease study 2019. Public Health. 2024;237:212\u201331. https:\/\/doi.org\/10.1016\/j.puhe.2024.06.011. From NLM.","journal-title":"Public Health"},{"issue":"1","key":"7921_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/yco.0000000000000903","volume":"37","author":"G Sampogna","year":"2024","unstructured":"Sampogna G, Toni C, Catapano P, Rocca BD, Di Vincenzo M, Luciano M, Fiorillo A. New trends in personalized treatment of depression. Curr Opin Psychiatry. 2024;37(1):3\u20138. https:\/\/doi.org\/10.1097\/yco.0000000000000903. From NLM.","journal-title":"Curr Opin Psychiatry"},{"key":"7921_CR4","doi-asserted-by":"publisher","unstructured":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396 (10258), 1204\u20131222. https:\/\/doi.org\/10.1016\/s0140-67362030925-9 From NLM.","DOI":"10.1016\/s0140-67362030925-9"},{"issue":"10328","key":"7921_CR5","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/s0140-6736(21)02141-3","volume":"399","author":"H Herrman","year":"2022","unstructured":"Herrman H, Patel V, Kieling C, Berk M, Buchweitz C, Cuijpers P, Furukawa TA, Kessler RC, Kohrt BA, Maj M, et al. Time for united action on depression: a Lancet-World Psychiatric Association Commission. Lancet. 2022;399(10328):957\u20131022. https:\/\/doi.org\/10.1016\/s0140-6736(21)02141-3. From NLM.","journal-title":"Lancet"},{"key":"7921_CR6","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jad.2021.08.036","volume":"295","author":"V P\u00e9rez-Sola","year":"2021","unstructured":"P\u00e9rez-Sola V, Roca M, Alonso J, Gabilondo A, Hernando T, Sicras-Mainar A, Sicras-Navarro A, Herrera B, Vieta E. Economic impact of treatment-resistant depression: A retrospective observational study. J Affect Disord. 2021;295:578\u201386. https:\/\/doi.org\/10.1016\/j.jad.2021.08.036. From NLM.","journal-title":"J Affect Disord"},{"issue":"31","key":"7921_CR7","doi-asserted-by":"publisher","first-page":"9350","DOI":"10.12998\/wjcc.v9.i31.9350","volume":"9","author":"R Karrouri","year":"2021","unstructured":"Karrouri R, Hammani Z, Benjelloun R, Otheman Y. Major depressive disorder: Validated treatments and future challenges. World J Clin Cases. 2021;9(31):9350\u201367. https:\/\/doi.org\/10.12998\/wjcc.v9.i31.9350. From NLM.","journal-title":"World J Clin Cases"},{"issue":"3","key":"7921_CR8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/wps.21120","volume":"22","author":"RS McIntyre","year":"2023","unstructured":"McIntyre RS, Alsuwaidan M, Baune BT, Berk M, Demyttenaere K, Goldberg JF, Gorwood P, Ho R, Kasper S, Kennedy SH, et al. Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry. 2023;22(3):394\u2013412. https:\/\/doi.org\/10.1002\/wps.21120. From NLM.","journal-title":"World Psychiatry"},{"key":"7921_CR9","doi-asserted-by":"publisher","first-page":"104585","DOI":"10.1016\/j.ajp.2025.104585","volume":"110","author":"G Corrivetti","year":"2025","unstructured":"Corrivetti G, Monaco F, Vignapiano A, Marenna A, Panarello E, Di Gruttola B, Landi S, Malvone R, Vecchi C, Leo S, et al. Precision medicine for depression: Improving treatment response and remission. Asian J Psychiatr. 2025;110:104585. https:\/\/doi.org\/10.1016\/j.ajp.2025.104585. From NLM.","journal-title":"Asian J Psychiatr"},{"issue":"Pt 1","key":"7921_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.brainresbull.2016.05.016","volume":"126","author":"Y Liu","year":"2016","unstructured":"Liu Y, Lin D, Wu B, Zhou W. Ketamine abuse potential and use disorder. Brain Res Bull. 2016;126(Pt 1):68\u201373. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.05.016. From NLM.","journal-title":"Brain Res Bull"},{"key":"7921_CR11","doi-asserted-by":"publisher","first-page":"h6019","DOI":"10.1136\/bmj.h6019","volume":"351","author":"HR Amick","year":"2015","unstructured":"Amick HR, Gartlehner G, Gaynes BN, Forneris C, Asher GN, Morgan LC, Coker-Schwimmer E, Boland E, Lux LJ, Gaylord S, et al. Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis. BMJ. 2015;351:h6019. https:\/\/doi.org\/10.1136\/bmj.h6019. From NLM.","journal-title":"BMJ"},{"issue":"1","key":"7921_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/17460441.2019.1546691","volume":"14","author":"X Gonda","year":"2019","unstructured":"Gonda X, Sharma SR, Tarazi FI. Vortioxetine: a novel antidepressant for the treatment of major depressive disorder. Expert Opin Drug Discov. 2019;14(1):81\u20139. https:\/\/doi.org\/10.1080\/17460441.2019.1546691. From NLM.","journal-title":"Expert Opin Drug Discov"},{"issue":"3","key":"7921_CR13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4088\/jcp.07m03780","volume":"70","author":"A Szegedi","year":"2009","unstructured":"Szegedi A, Jansen WT, van Willigenburg AP, van der Meulen E, Stassen HH, Thase ME. Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. J Clin Psychiatry. 2009;70(3):344\u201353. https:\/\/doi.org\/10.4088\/jcp.07m03780. From NLM.","journal-title":"J Clin Psychiatry"},{"issue":"16","key":"7921_CR14","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1017\/s0033291721003871","volume":"51","author":"M Sajjadian","year":"2021","unstructured":"Sajjadian M, Lam RW, Milev R, Rotzinger S, Frey BN, Soares CN, Parikh SV, Foster JA, Turecki G, M\u00fcller DJ, et al. Machine learning in the prediction of depression treatment outcomes: a systematic review and meta-analysis. Psychol Med. 2021;51(16):2742\u201351. https:\/\/doi.org\/10.1017\/s0033291721003871. From NLM.","journal-title":"Psychol Med"},{"issue":"5","key":"7921_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1017\/S0033291711001905","volume":"42","author":"R Uher","year":"2012","unstructured":"Uher R, Perlis RH, Henigsberg N, Zobel A, Rietschel M, Mors O, Hauser J, Dernovsek MZ, Souery D, Bajs M, et al. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychol Med. 2012;42(5):967\u201380. https:\/\/doi.org\/10.1017\/S0033291711001905.","journal-title":"Psychol Med"},{"key":"7921_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clinph.2024.02.004","volume":"160","author":"X Wang","year":"2024","unstructured":"Wang X, Xue L, Shao J, Dai Z, Hua L, Yan R, Yao Z, Lu Q. Distinct MRI-based functional and structural connectivity for antidepressant response prediction in major depressive disorder. Clin Neurophysiol. 2024;160:19\u201327. https:\/\/doi.org\/10.1016\/j.clinph.2024.02.004. From NLM.","journal-title":"Clin Neurophysiol"},{"key":"7921_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.euroneuro.2025.05.004","volume":"96","author":"V Oliva","year":"2025","unstructured":"Oliva V, Possidente C, Fanelli G, Domschke K, Minelli A, Gennarelli M, Martini P, Bortolomasi M, Squassina A, Pisanu C, et al. Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis. Eur Neuropsychopharmacol. 2025;96:17\u201327. https:\/\/doi.org\/10.1016\/j.euroneuro.2025.05.004. From NLM.","journal-title":"Eur Neuropsychopharmacol"},{"key":"7921_CR18","doi-asserted-by":"publisher","unstructured":"Sitarz R, Juchnowicz D, Karaku\u0142a K, Forma A, Baj J, Rog J, Karpi\u0144ski R, Machrowska A, Karaku\u0142a-Juchnowicz H. Niacin skin flush backs-from the roots of the test to nowadays hope. J Clin Med. 2023;12(5). https:\/\/doi.org\/10.3390\/jcm12051879.","DOI":"10.3390\/jcm12051879"},{"key":"7921_CR19","doi-asserted-by":"publisher","first-page":"110163","DOI":"10.1016\/j.abb.2024.110163","volume":"761","author":"A Javaid","year":"2024","unstructured":"Javaid A, Mudavath SL. Niacin-induced flushing: Mechanism, pathophysiology, and future perspectives. Arch Biochem Biophys. 2024;761:110163. https:\/\/doi.org\/10.1016\/j.abb.2024.110163.","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"7921_CR20","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1172\/jci36806","volume":"119","author":"RW Walters","year":"2009","unstructured":"Walters RW, Shukla AK, Kovacs JJ, Violin JD, DeWire SM, Lam CM, Chen JR, Muehlbauer MJ, Whalen EJ, Lefkowitz RJ. beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. J Clin Invest. 2009;119(5):1312\u201321. https:\/\/doi.org\/10.1172\/jci36806. From NLM.","journal-title":"J Clin Invest"},{"issue":"3","key":"7921_CR21","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s12035-017-0435-4PubMed","volume":"55","author":"T Yagami","year":"2018","unstructured":"Yagami T, Yamamoto Y, Koma H. Physiological and Pathological Roles of 15-Deoxy-\u220612,14-Prostaglandin J2 in the Central Nervous System and Neurological Diseases. Mol Neurobiol. 2018;55(3):2227\u201348. https:\/\/doi.org\/10.1007\/s12035-017-0435-4.","journal-title":"Mol Neurobiol"},{"issue":"5","key":"7921_CR22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.bcp.2005.11.019","volume":"71","author":"HJ Knowles","year":"2006","unstructured":"Knowles HJ, te Poele RH, Workman P, Harris AL. Niacin induces PPARgamma expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways. Biochem Pharmacol. 2006;71(5):646\u201356. https:\/\/doi.org\/10.1016\/j.bcp.2005.11.019. From NLM.","journal-title":"Biochem Pharmacol"},{"key":"7921_CR23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.schres.2022.07.017","volume":"248","author":"Y Qing","year":"2022","unstructured":"Qing Y, Liang J, Wang J, Wan C, Ke X. Attenuated niacin skin flushing response in children and adolescents with mental disorders: A transdiagnostic early warning marker. Schizophr Res. 2022;248:32\u20134. https:\/\/doi.org\/10.1016\/j.schres.2022.07.017. From NLM.","journal-title":"Schizophr Res"},{"issue":"2","key":"7921_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","volume":"107","author":"E Beurel","year":"2020","unstructured":"Beurel E, Toups M, Nemeroff CB. The Bidirectional Relationship of Depression and Inflammation: Double Trouble. Neuron. 2020;107(2):234\u201356. https:\/\/doi.org\/10.1016\/j.neuron.2020.06.002. From NLM.","journal-title":"Neuron"},{"issue":"1\u20133","key":"7921_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.schres.2010.03.025PubMed","volume":"122","author":"E Messamore","year":"2010","unstructured":"Messamore E, Hoffman WF, Yao JK. Niacin sensitivity and the arachidonic acid pathway in schizophrenia. Schizophr Res. 2010;122(1\u20133):248\u201356. https:\/\/doi.org\/10.1016\/j.schres.2010.03.025.","journal-title":"Schizophr Res"},{"key":"7921_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jad.2018.05.004PubMed","volume":"237","author":"M Shibata","year":"2018","unstructured":"Shibata M, Ohara T, Yoshida D, Hata J, Mukai N, Kawano H, Kanba S, Kitazono T, Ninomiya T. Association between the ratio of serum arachidonic acid to eicosapentaenoic acid and the presence of depressive symptoms in a general Japanese population: the Hisayama Study. J Affect Disord. 2018;237:73\u20139. https:\/\/doi.org\/10.1016\/j.jad.2018.05.004.","journal-title":"J Affect Disord"},{"key":"7921_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jad.2019.07.035PubMed","volume":"257","author":"M Gopaldas","year":"2019","unstructured":"Gopaldas M, Zanderigo F, Zhan S, Ogden RT, Miller JM, Rubin-Falcone H, Cooper TB, Oquendo MA, Sullivan G, Mann JJ, et al. Brain serotonin transporter binding, plasma arachidonic acid and depression severity: A positron emission tomography study of major depression. J Affect Disord. 2019;257:495\u2013503. https:\/\/doi.org\/10.1016\/j.jad.2019.07.035.","journal-title":"J Affect Disord"},{"issue":"6","key":"7921_CR28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.biopsych.2009.11.005PubMed","volume":"67","author":"K-P Su","year":"2010","unstructured":"Su K-P, Huang S-Y, Peng C-Y, Lai H-C, Huang C-L, Chen Y-C, Aitchison KJ, Pariante CM. Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biol Psychiatry. 2010;67(6):550\u20137. https:\/\/doi.org\/10.1016\/j.biopsych.2009.11.005.","journal-title":"Biol Psychiatry"},{"key":"7921_CR29","doi-asserted-by":"publisher","unstructured":"Wang J, Xie J, He F, Wu W, Xu K, Ren Y, Chen J, Xie P. Akkermansia muciniphila-derived SCFAs improve the depression-like behaviors of mice by inhibiting neuroinflammation. Pharmacol Res. 2025;107938. https:\/\/doi.org\/10.1016\/j.phrs.2025.107938. From NLM.","DOI":"10.1016\/j.phrs.2025.107938"},{"key":"7921_CR30","doi-asserted-by":"publisher","first-page":"771144","DOI":"10.3389\/fpsyt.2021.771144","volume":"12","author":"SH Ansarey","year":"2021","unstructured":"Ansarey SH. Inflammation and JNK\u2019s Role in Niacin-GPR109A Diminished Flushed Effect in Microglial and Neuronal Cells With Relevance to Schizophrenia. Front Psychiatry. 2021;12:771144. https:\/\/doi.org\/10.3389\/fpsyt.2021.771144. From NLM.","journal-title":"Front Psychiatry"},{"key":"7921_CR31","doi-asserted-by":"publisher","first-page":"115174","DOI":"10.1016\/j.intimp.2025.115174","volume":"162","author":"Z Cheng","year":"2025","unstructured":"Cheng Z, Qian T, Yu J, Yan Y, Jing L, Yang B, Tang H, Yan A, Liu M, Song Y, et al. The niacin receptor HCAR2 prevents sleep deprivation-induced cognitive impairment by inhibiting microglia-mediated neuroinflammation in mice. Int Immunopharmacol. 2025;162:115174. https:\/\/doi.org\/10.1016\/j.intimp.2025.115174. From NLM.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"7921_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jad.2003.11.005","volume":"82","author":"BM Ross","year":"2004","unstructured":"Ross BM, Ward P, Glen I. Delayed vasodilatory response to methylnicotinate in patients with unipolar depressive disorder. J Affect Disord. 2004;82(2):285\u201390. PubMed.","journal-title":"J Affect Disord"},{"key":"7921_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jad.2022.12.017","volume":"324","author":"J Wang","year":"2023","unstructured":"Wang J, Qing Y, Liang J, Cui G, Wang Q, Zhang J, Yang X, Li M, Wang D, Fan Z, et al. Identification of adolescent patients with depression via assessment of the niacin skin flushing response. J Affect Disord. 2023;324:69\u201376. https:\/\/doi.org\/10.1016\/j.jad.2022.12.017. From NLM.","journal-title":"J Affect Disord"},{"issue":"1","key":"7921_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s40168-023-01635-6","volume":"11","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhou J, Ye J, Sun Z, He Y, Zhao Y, Ren S, Zhang G, Liu M, Zheng P, et al. Multi-omics reveal microbial determinants impacting the treatment outcome of antidepressants in major depressive disorder. Microbiome. 2023;11(1):195. https:\/\/doi.org\/10.1186\/s40168-023-01635-6. From NLM.","journal-title":"Microbiome"},{"issue":"1","key":"7921_CR35","doi-asserted-by":"publisher","first-page":"19018","DOI":"10.1038\/s41598-024-70097-z","volume":"14","author":"P Ninla-Aesong","year":"2024","unstructured":"Ninla-Aesong P, Kietdumrongwong P, Neupane SP, Puangsri P, Jongkrijak H, Chotipong P, Kaewpijit P. Relative value of novel systemic immune-inflammatory indices and classical hematological parameters in predicting depression, suicide attempts and treatment response. Sci Rep. 2024;14(1):19018. https:\/\/doi.org\/10.1038\/s41598-024-70097-z. From NLM.","journal-title":"Sci Rep"},{"key":"7921_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5093\/ejpalc2018a5","volume":"10","author":"JF Salgado","year":"2018","unstructured":"Salgado JF. Transforming the Area under the Normal Curve (AUC) into Cohen s d, Pearson s r pb, Odds-Ratio, and Natural Log Odds-Ratio: Two Conversion Tables. Eur J Psychol Appl Legal Context. 2018;10:35\u201347.","journal-title":"Eur J Psychol Appl Legal Context"},{"issue":"2","key":"7921_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4088\/JCP.16m10641PubMed","volume":"78","author":"M Zimmerman","year":"2017","unstructured":"Zimmerman M, Walsh E, Friedman M, Boerescu DA, Attiullah N. Identifying Remission From Depression on 3 Self-Report Scales. J Clin Psychiatry. 2017;78(2):177\u201383. https:\/\/doi.org\/10.4088\/JCP.16m10641.","journal-title":"J Clin Psychiatry"},{"key":"7921_CR38","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.phrs.2017.04.028","volume":"121","author":"E Alcocer-G\u00f3mez","year":"2017","unstructured":"Alcocer-G\u00f3mez E, Casas-Barquero N, Williams MR, Romero-Guillena SL, Ca\u00f1adas-Lozano D, Bull\u00f3n P, S\u00e1nchez-Alcazar JA, Navarro-Pando JM, Cordero MD. Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in Major depressive disorder. Pharmacol Res. 2017;121:114\u201321. https:\/\/doi.org\/10.1016\/j.phrs.2017.04.028. From NLM.","journal-title":"Pharmacol Res"},{"key":"7921_CR39","doi-asserted-by":"publisher","first-page":"109521","DOI":"10.1016\/j.cellsig.2019.109521","volume":"68","author":"S Ghosh","year":"2020","unstructured":"Ghosh S, Choudhury S, Chowdhury O, Mukherjee S, Das A, Sain A, Gupta P, Adhikary A, Chattopadhyay S. Inflammation-induced behavioral changes is driven by alterations in Nrf2-dependent apoptosis and autophagy in mouse hippocampus: Role of fluoxetine. Cell Signal. 2020;68:109521. https:\/\/doi.org\/10.1016\/j.cellsig.2019.109521. From NLM.","journal-title":"Cell Signal"},{"issue":"2","key":"7921_CR40","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41380-019-0474-5PubMed","volume":"25","author":"JJ Liu","year":"2020","unstructured":"Liu JJ, Wei YB, Strawbridge R, Bao Y, Chang S, Shi L, Que J, Gadad BS, Trivedi MH, Kelsoe JR, et al. Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis. Mol Psychiatry. 2020;25(2):339\u201350. https:\/\/doi.org\/10.1038\/s41380-019-0474-5.","journal-title":"Mol Psychiatry"},{"issue":"4","key":"7921_CR41","doi-asserted-by":"publisher","first-page":"e12516","DOI":"10.1111\/appy.12516","volume":"14","author":"R Gan","year":"2022","unstructured":"Gan R, Zhao Y, Wu G, Zeng J, Hu Y, Xu L, Wei Y, Tang X, Liu X, Liu H, et al. Replication of the abnormal niacin response in first episode psychosis measured using laser Doppler flowmeter. Asia Pac Psychiatry. 2022;14(4):e12516. https:\/\/doi.org\/10.1111\/appy.12516. From NLM.","journal-title":"Asia Pac Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-07921-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-07921-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-07921-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:54:21Z","timestamp":1775033661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-07921-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7921"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-07921-5","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent after being comprehensively advised of the study\u2019s purpose, procedures, potential risks, and anticipated benefits.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"278"}}